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Abstract
Introduction
Gestational  diabetes  and  pregnancy-related  hyperten-
sion  can  lead  to  adverse  health  effects  in  mothers  and 
infants. We assessed recent trends in the rates of these 
conditions in Los Angeles County, California.
Methods
Hospital discharge data were used to identify all women 
aged 15–54 years who resided in the county, had a single-
ton delivery from 1991 through 2003, and had gestational 
diabetes or pregnancy-related hypertension listed as a dis-
charge diagnosis at the time of delivery. The prevalence of 
each condition was calculated by calendar year, race/eth-
nicity, and age group. Temporal trends in the rates were 
assessed  by  using  negative  binomial  regression  models, 
controlling  for  race/ethnicity  and  age.  Separate  models 
were run for each racial/ethnic and age group.
Results
The  age-adjusted  prevalence  of  gestational  diabetes 
increased more than threefold (from 14.5 cases per 1000 
women in 1991 to 47.9 cases per 1000 in 2003). The age-
adjusted  prevalence  of  pregnancy-related  hypertension 
also increased (from 40.5 cases per 1000 in 1991 to 54.4 
cases per 1000 in 2003). In the multivariable regression 
analysis, the annual rate increase for gestational diabe-
tes was 8.3% overall and was highest among Hispanics 
(9.9%).  The  annual  rate  increase  for  pregnancy-related 
hypertension  was  2.8%  overall  and  was  highest  among 
blacks (4.8%).
Conclusion
The  rates  of  gestational  diabetes  and  pregnancy- 
related hypertension are increasing in Los Angeles County. 
Further research is needed to determine the causes of the 
observed increases and the growing racial/ethnic dispari-
ties in those rates.
Introduction
Gestational  diabetes  and  pregnancy-related  hyperten-
sion are associated with adverse health effects among both 
mothers  and  infants.  Gestational  diabetes  increases  the 
risk for preterm and cesarean delivery and type 2 diabetes 
in  the  mother  (1-5)  and  macrosomia,  hyperinsulinemia, 
and  future  obesity  and  diabetes  in  the  infant  (4,6-9). 
Pregnancy-related hypertension increases the risk for pre-
term and cesarean delivery, renal dysfunction, placental 
abruption, chronic hypertension, and death in the mother 
(10-12) and respiratory distress syndrome and fetal growth 
restriction  in  the  infant  (10,13,14).  Gestational  diabetes 
occurs in approximately 4% of pregnancies and ranges from 
1% to 14% among different racial/ethnic groups (15). Asian 
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and  Hispanic  mothers  have  the  highest  rates,  whereas 
white mothers have the lowest (16-19). The prevalence of 
pregnancy-related hypertension ranges from 6% to 8% and 
also varies by race/ethnicity; black mothers have the high-
est rates and white mothers have the lowest (12,13,19).
Several  studies  have  shown  that  the  prevalence  of 
gestational  diabetes  has  increased  (16,17,20),  but  only 
one  population-based  study  has  described  trends  in 
pregnancy-related  hypertension  (21).  No  studies  have 
investigated  trends  in  both  conditions  over  time  while 
also considering racial/ethnic and age distributions. We 
investigated  whether  the  rates  of  gestational  diabetes 
and  pregnancy-related  hypertension  are  on  the  rise  in 
Los Angeles County, California, which has a large, urban 
population with substantial racial/ethnic diversity.
Methods
Study sample
For this analysis, we extracted data from the California 
Inpatient  Hospital  Discharge  Data  Files  (1991–2003) 
obtained from the California Office of Statewide Health 
Planning  and  Development.  These  data  files  include   
individual-level  patient  discharge  data  for  all  licensed 
acute-care  hospitals  in  California;  each  file  contains  no 
more than 20 procedure and diagnosis codes.
We included all Los Angeles County residents aged 15–54 
years who were discharged from a California hospital after 
a singleton delivery during 1991–2003 by selecting records 
that  had  at  least  one  of  the  following  delivery-related 
(vaginal or cesarean) codes: International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 
(22)  diagnosis  codes  650–652,  inpatient  procedure  codes 
72–74,  or  Diagnosis-Related  Group  codes  370–375.  We 
excluded from the analysis women who had a multiple-
gestation  delivery  because  they  have  a  higher  risk  for 
pregnancy-related hypertension and gestational diabetes 
than do women with singleton pregnancies. A comparison 
conducted with birth certificate records indicated that more 
than 99% of all singleton births to Los Angeles County resi-
dents were captured in the hospital discharge data.
We  used  hospital  discharge  codes  to  identify  women 
who had gestational diabetes or pregnancy-related hyper-
tension. For gestational diabetes, we selected all records 
containing the ICD-9-CM discharge code 648.8 (abnormal 
glucose tolerance/gestational diabetes complicating preg-
nancy,  childbirth,  or  the  puerperium).  For  pregnancy-
related hypertension, we selected records containing the 
ICD-9-CM discharge code 642 (hypertension complicating 
pregnancy, childbirth, and the puerperium).
Statistical analyses
To determine the prevalence of gestational diabetes and 
pregnancy-related  hypertension  in  Los  Angeles  County 
for 1991–2003, we calculated the age-adjusted prevalence 
rate (number of women with the condition listed on the 
discharge record per 1000 women hospitalized for a single-
ton birth) for each condition, by year. The prevalence of 
each condition was calculated for the sample as a whole 
and for each racial/ethnic and age group. Age groups were 
divided into the following categories: 15–24 years, 25–34 
years, and 35–54 years. The age distribution of women 
who delivered in the United States in 2003 was used as 
the standard population.
Temporal  trends  in  the  rates  of  gestational  diabetes 
and pregnancy-related hypertension for 1991–2003 were 
assessed  by  using  negative  binomial  regression  with  a 
log-link function. This analytical technique was used to 
correct for any overdispersion in the data. First, regression 
models that included all the women in the sample were 
calculated for each condition. These models contained the 
variables of year, age group, and race/ethnicity; the inde-
pendent  variable  of  interest  was  year,  which  described 
the average annual change in rates across time. Second, 
separate models were run for each racial/ethnic group to 
determine whether rates for each condition changed differ-
entially by race/ethnicity, after controlling for age group. 
Finally, models were run for each age group, controlling 
for  race/ethnicity.  The  racial/ethnic  categories  included 
in the multivariable models were white, black, Hispanic, 
Asian/Pacific Islander, and other/unknown, although we 
do not present race/ethnicity-specific results for women in 
the other/unknown category. All statistical analyses were 
conducted with the SAS statistical package, version 10.0 
(SAS Institute Inc, Cary, North Carolina).
Results
From  1991  through  2003,  a  total  of  2,156,459  Los 
Angeles County residents were hospitalized for a singleton 
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declined from 1991 to 2003, which reflected a decline in 
the birth rate rather than a decrease in the number of 
women of childbearing age. The racial/ethnic distribution 
of women who gave birth changed over the course of the 
study period: Hispanics accounted for an increasing per-
centage and whites accounted for a decreasing percentage 
of women giving birth (Table 1).
The  age  distribution  of  women  who  gave  birth  also 
changed  during  the  study  period.  Women  aged  15–24 
accounted for a smaller percentage of women who gave 
birth in 2003 than in 1991, whereas women aged 35–54 
accounted for a larger percentage in 2003 than in 1991 
(Table 1). This trend toward increasing maternal age was 
observed in all racial/ethnic groups.
Gestational diabetes
The age-adjusted prevalence of gestational diabetes for 
the entire study sample increased steadily from 14.5 cases 
per 1000 women in 1991 to 47.9 cases per 1000 women 
in 2003 (Figure 1). The prevalence among Asian/Pacific 
Islander women was the highest among all racial/ethnic 
groups throughout the study period, but Hispanic women 
had the highest overall increase in prevalence during the 
study period. White women had the lowest prevalence and 
relative rate increase.
Gestational  diabetes  prevalence  was  highest  among 
women aged 35–54. However, the rates for all age groups 
increased  during  the  study  period.  The  rates  per  1000 
women  increased  more  than  3.5-fold  among  those  aged 
15–24 (from 4.8 in 1991 to 17.5 in 2003), approximately 4-
fold among those aged 25–34 (from 15.1 to 55.2), and more 
than 2.5-fold for those aged 35–54 (from 37.1 to 98.2).
From 1991 through 2003, the annual rate increase for 
gestational  diabetes  among  all  women,  controlling  for 
race/ethnicity  and  age,  was  8.3%  (Table  2).  When  the 
models were run separately by race/ethnicity, controlling 
for age, Hispanics had the highest annual rate increase, 
followed by Asian/Pacific Islanders, blacks, and whites.
Women aged 15–24 had the highest increase per year 
in gestational diabetes, while women aged 35–54 had the 
lowest increase per year (Table 2). Among the racial/ethnic 
groups, Asian/Pacific Islander women aged 15–24 had the 
highest increase, followed by Hispanic women aged 25–34. 
Among women aged 35–54, Hispanics and blacks had the 
greatest increases per year.
Pregnancy-related hypertension
The age-adjusted prevalence of pregnancy-related hyper-
tension for the entire sample increased from 40.5 per 1000 
women in 1991 to 54.4 per 1000 women in 2003 (Figure 2). 
Black women had the highest overall prevalence as well 
as the largest increase; rates for Hispanic women were 
the second highest during the study period, while Asian/
Pacific Islander women had the lowest overall prevalence 
and rate increase.
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Figure 1. Age-Adjusted Rates of Gestational Diabetes Among All Women 
and by Race/Ethnicity — Los Angeles County, California, 1991–2003 
Figure 2. Age-Adjusted Rates of Pregnancy-Related Hypertension Among 
All Women and by Race/Ethnicity — Los Angeles County, California, 1991–
2003 VOLUME 5: NO. 3
JULY 2008
The prevalence of pregnancy-related hypertension per 
1000 women increased the most among women aged 15–
24, from 37.6 in 1991 to 57.0 in 2003. The prevalence also 
increased among women aged 25–34 (from 36.2 to 48.1) 
and those aged 35–54 (from 63.3 to 70.0).
Rates  for  pregnancy-related  hypertension  increased 
2.8% per year among all women during the study period 
(Table 3). Black women had the highest annual increase, 
followed by white women. Asian/Pacific Islander women 
had the lowest increase per year.
The  prevalence  of  pregnancy-related  hypertension 
increased most in women aged 15–24 and least in those 
aged  35–54  (Table  3).  Black  women  had  the  highest 
increase within each age group, and black women aged 
15–24 had the largest increase of all age and racial/ethnic 
groups. White, Asian/Pacific Islander, and Hispanic women 
had similar increases among all age groups, except among 
those aged 35–54, where whites had a larger increase. The 
results  for  Hispanic  and  Asian/Pacific  Islander  women 
aged 35–54 were not statistically significant.
All analyses were repeated excluding women with preex-
isting diabetes and hypertension, which accounted for 1% 
(n = 22,786) and 0.2% (n = 5184) of the total sample, respec-
tively. The results were unchanged (data not shown).
Discussion
Our findings demonstrate that age-adjusted prevalences 
of gestational diabetes and pregnancy-related hyperten-
sion increased among women in Los Angeles County from 
1991 through 2003. The increase in rates of gestational 
diabetes was especially pronounced and was higher than 
that  observed  in  another  large,  multiethnic  population 
study (20). However, this latter study was done in a pri-
vate  health-maintenance  organization  population  that 
may have had greater access to prenatal care than did 
women  in  our  study,  which  included  women  without 
health insurance as well as those with public and private 
insurance.
We  found  increases  in  gestational  diabetes  and   
pregnancy-related  hypertension  among  all  racial/ethnic 
and age groups studied. However, the age-adjusted rates 
of gestational diabetes were highest among Hispanic and 
Asian/Pacific Islander mothers and lowest among white 
mothers,  whereas  the  age-adjusted  rates  of  pregnancy-
related hypertension were highest among black mothers 
and lowest among Asian/Pacific Islander mothers. These 
racial/ethnic differences are consistent with findings of pre-
vious studies (18,23-25). Older mothers had higher rates 
of  both  conditions  than  did  their  younger  counterparts, 
which is also consistent with other studies (14,15,25).
The  observed  increases  in  gestational  diabetes  and 
pregnancy-related hypertension from 1991 through 2003 
persisted after controlling for age and race/ethnicity in 
multivariable  analyses.  The  race/ethnicity-specific  rate 
increase  was  highest  for  gestational  diabetes  among 
Hispanic  mothers  and  highest  for  pregnancy-related 
hypertension  among  black  mothers.  The  highest  age- 
specific rate increase of gestational diabetes was observed 
among the youngest age group (15–24 years) of Asian/
Pacific Islander mothers, and similarly, the highest rate 
increase of pregnancy-related hypertension was observed 
among the youngest age group of black mothers.
Our study had several strengths. First, our data cap-
tured  nearly  all  births  in  Los  Angeles  County,  a  large 
and highly diverse population, during a 13-year period. 
Second, this study is, to our knowledge, the first to report 
population-based trends in both gestational diabetes and 
pregnancy-related hypertension. Third, we controlled for 
race/ethnicity and age in the analysis and analyzed trends 
separately for each racial/ethnic and age group. Because 
race/ethnicity  and  age  are  strong  risk  factors  for  both 
conditions,  understanding  how  the  rates  change  inde-
pendently of these factors is important given the change 
in  racial/ethnic  demographics  in  Los  Angeles  and  the 
increasing proportion of births among older women.
Other studies have reported increases in the prevalence 
of gestational diabetes, including racial/ethnic disparities 
(16,17,20,26) and a greater relative increase in prevalence 
among younger women (17). However, only one of these 
studies  captured  information  on  all  mothers  who  gave 
birth  in  the  target  population,  and  this  study  did  not 
control for race/ethnicity or age (17). One previous study 
investigated trends in hypertensive diseases in pregnancy 
and found, in contrast to our findings, a decrease in these 
conditions (21). However, that study relied solely on birth 
certificate data, which may be less sensitive than hospital 
discharge  data  or  medical  record  review  in  identifying 
cases (27).
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ses were based on hospital discharge codes and did not 
include medical chart review. Though hospital discharge 
records have been reported to accurately determine rates 
of gestational diabetes (28), we cannot rule out the pos-
sibility that the observed increases may have been due to 
increased coding of gestational diabetes and pregnancy-
related hypertension as discharge diagnoses because of 
change  in  hospital  policies  or  coding  errors.  A  second 
limitation is that we could not directly assess the degree 
to which increased screening or changes in diagnostic cri-
teria might have influenced our findings. However, diag-
nostic criteria and screening guidelines did not change 
during  our  study  (29-31),  so  this  limitation  is  unlikely 
to substantially bias our findings. A third limitation is 
that we did not have data on other factors that may have 
contributed  to  an  increase  in  gestational  diabetes  and 
pregnancy-related  hypertension,  in  particular  data  on 
maternal weight. During the past decade, the prevalence 
of obesity has increased among women of childbearing age 
in the United States and in Los Angeles County (32,33, 
M. Shih, written communication, April 2006), and obesity 
increases the risk of gestational diabetes and pregnancy-
related hypertension by as much as 5-fold (15,17,23,33). 
Our results are consistent with other research that has 
found  a  parallel  increase  in  gestational  diabetes  and 
obesity prevalence among women of childbearing age in 
a large, urban setting (17). Further research is needed 
to  determine  the  degree  to  which  the  obesity  epidemic 
might be contributing to an increase in rates of gesta-
tional diabetes and pregnancy-related hypertension. Our 
findings highlight the need for enhanced surveillance of 
gestational  diabetes,  pregnancy-related  hypertension, 
and maternal weight. This surveillance could be accom-
plished through medical record review at sentinel health 
care sites or collection of data on birth certificates.
Our  findings  also  underscore  the  need  to  further 
investigate  the  racial/ethnic  disparities  in  the  preva-
lence  rates  and  rate  increases  of  gestational  diabe-
tes  and  pregnancy-related  hypertension.  Our  results 
are  consistent  with  findings  that  minority  women 
are  at  higher  risk  of  gestational  diabetes  (16-19)  and   
pregnancy-related  hypertension  (12,13,19).  The  causes 
of the disproportion are unclear, although biological, cul-
tural, and socioeconomic factors may all play a role. One 
study found that the biological response to lipid and car-
bohydrate metabolism in Asian-born women puts them 
at  higher  risk  of  gestational  diabetes  compared  with 
white women (18). Another study found that maternal 
and paternal ethnicity affected the risk of preeclampsia. 
Women  whose  mothers  were  black  or  whose  parents 
were of different races or ethnicities were at increased 
risk of preeclampsia, whereas those whose fathers were 
Asian  had  the  lowest  risk,  which  suggests  a  possible 
genetic or cultural influence or combination of the two 
(25). Socioeconomic and cultural factors may also predis-
pose nonwhite or Hispanic women to unhealthful diets 
and obesity (17) and reduce access to prenatal care (34). 
However, other research found that even after control-
ling for early access to prenatal care, minority women 
were still more likely to have poor perinatal outcomes, 
including  gestational  diabetes  and  preeclampsia  (35), 
which suggests that health care access and healthy life-
style are crucial even before conception (36).
Health care systems should ensure that women have 
timely  access  to  preconception  and  prenatal  care  that 
effectively addresses risks for and management of ges-
tational  diabetes  and  pregnancy-related  hypertension. 
Early identification and clinical management of women 
at risk for these conditions is critical. Health care pro-
viders  should  counsel  women  at  risk  on  prevention 
measures such as nutrition, weight and stress manage-
ment, and early and continual monitoring of gestational 
diabetes and pregnancy-related hypertension throughout 
the pregnancy. Community education efforts for women 
of  childbearing  age  are  also  needed  to  reinforce  the 
importance  of  healthy  diets,  regular  physical  activity, 
and  maintaining  a  healthy  weight  before  and  during 
pregnancy.
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Tables
Table 1. Demographic Characteristics of Los Angeles County, California Residents Hospitalized for a Singleton Birth in 1991 
and 2003
Characteristic 1991 (N = 198,162), n (%)a 2003 (N = 147,950), n (%)a
Race/ethnicity
White 50,398 (25.) 31,579 (21.3)
Hispanic 109,715 (55.) 88,035 (59.5)
Black 19,75 (9.9) 11,15 (7.5)
Asian/Pacific Islander 1,121 (8.1) 13,12 (8.9)
Other/unknown 2253 (1.1) 018 (2.7)
Age, y
15–2 77,275 (39.0) 7,077 (31.8)
25–3 98,517 (9.7) 75,51 (51.1)
35–5 22,370 (11.3) 25,312 (17.1)
 
a Percentages may not total 100% because of rounding.
Table 2. Annual Percentage Increase in Gestational Diabetes by Race/Ethnicity and Age, Los Angeles County, California, 
1991–2003a 
Race/Ethnicity
Annual % Increase (95% Confidence Interval)
Age Group
All Womenb 15–24 y 25–34 y 35–54 y
White 8.3 (7.1–9.5) 8.1 (7.0–9.3) 5.5 (.8–.2) 7.1 (.–7.9)
Hispanic 10. (8.3–12.) 10.8 (9.0–12.5) 8.5 (.7–10.0) 9.9 (8.8–11.0)
Black 8. (5.7–11.1) 7.7 (.7–8.8) 8.0 (.–9.5) 7.9 (7.1–8.8)
Asian/Pacific Islander 12.1 (9.1–15.2) 10.0 (8.–11.5) .0 (5.0–7.0) 8.7 (7.–9.8)
All womenc 9.5 (8.3–10.7) 9.1 (8.3–9.8) .8 (.1–7.5) 8.3 (7.–9.0)
 
a All results significant at the P < .001 level. 
b Adjusted for age. 
c Adjusted for race/ethnicity; includes those in the other/unknown racial/ethnic category.
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and does not imply endorsement by any of the groups named above.Table 3. Annual Percentage Increase in Pregnancy-Related Hypertension by Race/Ethnicity and Age, Los Angeles County, 
California, 1991–2003a 
Race/Ethnicity
Annual % Increase (95% Confidence Interval)
Age Group
All Womenb 15–24 y 25–34 y 35–54 y
White 3.8 (2.7–.8) 2.5 (1.9–3.1) 1.5 (0.7–2.) 2. (2.0–3.1)
Hispanic 3.3 (2.7–3.9) 2.5 (2.1–2.8) 0.1 (0.01–1.)c 2.3 (1.8–2.7)
Black 5.8 (.7–7.0) 5.3 (.2–.3) 2.8 (2.1–3.5) .8 (.1–5.5)
Asian/Pacific Islander 3.9 (2.2–5.) 2.2 (1.2–3.2) 0.2 (0.01–1.8)d 1.8 (0.9–2.7)
All Womene .1 (3.–.7) 3.0 (2.–3.) 1.2 (0.7–1.7) 2.8 (2.–3.3)
 
a Except where noted otherwise, all results significant at the P < .001 level. 
b Adjusted for age. 
c P = .0. 
d P = .78. 
e Adjusted for race/ethnicity; includes those in the other/unknown racial/ethnic category.
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